INVA Stock Analysis: Buy, Sell, or Hold?
INVA - Innoviva, Inc. Common Stock
$23.64
0.09 (0.38%)
▲
5d:
+4.56%
30d:
+5.25%
90d:
+7.85%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When INVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INVA shows positive signals but monitor for confirmation. Market pricing in 0.9% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: INVA shows positive signals but monitor for confirmation. Market pricing in 0.9% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.63
Based on 9.9% avg growth
INTRINSIC VALUE TODAY
$22.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INVA is currently trading at $23.64, which is considered extended relative to its 30-day fair value range of $21.78 to $22.90. The stock's valuation (Forward PE: 10.7) is in line with its historical norms (10.4). At these levels, the market is pricing in 0.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INVA is showing sideways momentum. The price is approaching resistance at $24.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.50 (+50.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INVA is showing sideways momentum. The price is approaching resistance at $24.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.50 (+50.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.78 -
$22.90
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.2% below Wall St target ($35.50)
- NEUTRAL: Market pricing in 0.9% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$21.78 -
$22.90
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.20
(5.1%)
Support & Resistance Levels
Support Level
$22.22
Resistance Level
$24.17
Current Trend
Sideways
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.70
Wall Street Target
$35.50
(+50.2%)
Revenue Growth (YoY)
10.6%
Earnings Growth (YoY)
590.4%
Profit Margin
119.9%
Valuation Premium vs History
+0.9% premium
PE vs Historical
10.7 vs 10.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$23.85
(+1%)
2-Year Target
$24.07
(+2%)
3-Year Target
$24.28
(+3%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$23.61
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 15.7%)
$74.56
(+215%)
Base:
(SPY PE: 10.7, Growth: 15.7%)
$36.62
(+55%)
Bear:
(PE: 9.1, Growth: 15.7%)
$31.13
(+32%)
📈
Valuation based on Current Earnings
Trailing PE: 3.62 | Current EPS (TTM): $6.26
Bull Case
$12.47
(-47%)
Analyst growth -50.0%, PE expands to 4.0
Base Case
$11.33
(-52%)
Market implied -50.0%, PE stable at 3.6
Bear Case
$15.42
(-35%)
Severe decline -20.0%, PE contracts to 3.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 24, 2026 5:19 PM ET
Data refreshes hourly during market hours. Next update: 6:18 PM
Data refreshes hourly during market hours. Next update: 6:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 61 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 63 BUY |
Advanced INVA Option Strategies
Professional options setups generated by AI based on today's INVA price and gamma walls.
